Amrita Sule

535 total citations
9 papers, 83 citations indexed

About

Amrita Sule is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amrita Sule has authored 9 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amrita Sule's work include DNA Repair Mechanisms (6 papers), Glioma Diagnosis and Treatment (4 papers) and PARP inhibition in cancer therapy (3 papers). Amrita Sule is often cited by papers focused on DNA Repair Mechanisms (6 papers), Glioma Diagnosis and Treatment (4 papers) and PARP inhibition in cancer therapy (3 papers). Amrita Sule collaborates with scholars based in United States, United Kingdom and China. Amrita Sule's co-authors include Ranjit S. Bindra, Ranjini K. Sundaram, Juan C. Vasquez, Kristoffer Valerie, Lawrence F. Povirk, Sarah E. Golding, Jason M. Beckta, Hu Yang, Daiki Ueno and Christopher S. Hong and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Amrita Sule

9 papers receiving 81 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amrita Sule United States	6	64	34	19	10	8	9	83
Adrienne Weeks Canada	5	55 0.9×	19 0.6×	17 0.9×	13 1.3×	4 0.5×	12	92
Sonja J. Gill United Kingdom	3	55 0.9×	57 1.7×	8 0.4×	8 0.8×	3 0.4×	5	83
Veerin R. Sirihorachai United States	2	33 0.5×	42 1.2×	14 0.7×	15 1.5×	9 1.1×	3	65
Katayoon Kasaian Canada	2	29 0.5×	25 0.7×	10 0.5×	16 1.6×	5 0.6×	2	70
Valentina Robustelli Italy	6	63 1.0×	39 1.1×	10 0.5×	13 1.3×	4 0.5×	13	103
Geronimo Dubra France	3	53 0.8×	24 0.7×	5 0.3×	11 1.1×	11 1.4×	3	102
Polly Talley United Kingdom	5	58 0.9×	22 0.6×	11 0.6×	6 0.6×	19 2.4×	7	101
Sabine Stainczyk Germany	6	51 0.8×	20 0.6×	11 0.6×	27 2.7×	4 0.5×	7	88
Daniel de la Nava Spain	5	34 0.5×	39 1.1×	15 0.8×	10 1.0×	26 3.3×	10	80
Nathan R. Fons United States	4	31 0.5×	25 0.7×	13 0.7×	14 1.4×	10 1.3×	5	81

Countries citing papers authored by Amrita Sule

Since Specialization

Citations

This map shows the geographic impact of Amrita Sule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amrita Sule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amrita Sule more than expected).

Fields of papers citing papers by Amrita Sule

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amrita Sule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amrita Sule. The network helps show where Amrita Sule may publish in the future.

Co-authorship network of co-authors of Amrita Sule

This figure shows the co-authorship network connecting the top 25 collaborators of Amrita Sule. A scholar is included among the top collaborators of Amrita Sule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amrita Sule. Amrita Sule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sule, Amrita, et al.. (2022). Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma. Scientific Reports. 12(1). 5827–5827. 11 indexed citations

Ueno, Daiki, Juan C. Vasquez, Amrita Sule, et al.. (2022). Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy. Oncotarget. 13(1). 1054–1067. 11 indexed citations

Sule, Amrita, Sarah E. Golding, Syed Farhan Ahmad, et al.. (2022). ATM phosphorylates PP2A subunit A resulting in nuclear export and spatiotemporal regulation of the DNA damage response. Cellular and Molecular Life Sciences. 79(12). 603–603. 6 indexed citations

Sule, Amrita, et al.. (2021). Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors. NAR Cancer. 3(2). zcab018–zcab018. 25 indexed citations

Hong, Christopher S., Juan C. Vasquez, Adam J. Kundishora, et al.. (2020). Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma. npj Genomic Medicine. 5(1). 23–23. 4 indexed citations

Hong, Christopher S., Amrita Sule, Jason M. Beckta, Ranjini K. Sundaram, & Ranjit S. Bindra. (2020). Abstract 1389: Exploiting inherent DNA damage repair defects in IDH1/2 mutated gliomas with the CNS penetrant PARP inhibitor, pamiparib. Cancer Research. 80(16_Supplement). 1389–1389. 1 indexed citations

Wang, Juan, O. Yu. Zolotarskaya, Amrita Sule, et al.. (2020). PEAMOtecan, a novel chronotherapeutic polymeric drug for brain cancer. Journal of Controlled Release. 321. 36–48. 7 indexed citations

Kahn, Jonathan B., John Allen, Jeremy Karlin, et al.. (2017). Next-Generation ATM Kinase Inhibitors Under Development Radiosensitize Glioblastoma With Conformal Radiation in a Mouse Orthotopic Model. International Journal of Radiation Oncology*Biology*Physics. 99(2). E600–E601. 3 indexed citations

Beckta, Jason M., Seth M. Dever, Ashraf Khalil, et al.. (2015). Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining. Oncotarget. 6(29). 27674–27687. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact